Literature DB >> 8064820

Molecular characterisation of type 1 Gaucher disease families and patients: intrafamilial heterogeneity at the clinical level.

O Amaral1, A M Fortuna, L Lacerda, R Pinto, M C Sa Miranda.   

Abstract

Type 1 Gaucher disease families were studied in an attempt to establish a phenotype/genotype correlation in affected persons and also to identify carriers accurately. In the Portuguese type 1 Gaucher patients, screening for mutations N370S, L444P, R463C, and 1066 + 1 G-->A allowed the identification of 85% of the alleles among unrelated patients. A subclinical case with genotype N370S/1066 + 1 G-->A was identified in one family in which there were three other symptomatic sibs. To our knowledge this is the first subclinical case with a genotype other than N370S/N370S. No genotype-phenotype correlation could be established and considerable clinical heterogeneity was found even among sibs with the same genotype. The data collected on the origins of the Gaucher families indicated two areas in northern Portugal where a higher frequency of the disease may be expected to exist.

Entities:  

Mesh:

Year:  1994        PMID: 8064820      PMCID: PMC1049874          DOI: 10.1136/jmg.31.5.401

Source DB:  PubMed          Journal:  J Med Genet        ISSN: 0022-2593            Impact factor:   6.318


  24 in total

1.  Genetic heterogeneity in type 1 Gaucher disease: multiple genotypes in Ashkenazic and non-Ashkenazic individuals.

Authors:  S Tsuji; B M Martin; J A Barranger; B K Stubblefield; M E LaMarca; E I Ginns
Journal:  Proc Natl Acad Sci U S A       Date:  1988-04       Impact factor: 11.205

2.  Characterization of mutations in Gaucher patients by cDNA cloning.

Authors:  M Wigderson; N Firon; Z Horowitz; S Wilder; Y Frishberg; O Reiner; M Horowitz
Journal:  Am J Hum Genet       Date:  1989-03       Impact factor: 11.025

3.  The human glucocerebrosidase gene and pseudogene: structure and evolution.

Authors:  M Horowitz; S Wilder; Z Horowitz; O Reiner; T Gelbart; E Beutler
Journal:  Genomics       Date:  1989-01       Impact factor: 5.736

4.  Comparison of RNase A, a chemical cleavage and GC-clamped denaturing gradient gel electrophoresis for the detection of mutations in exon 9 of the human acid beta-glucosidase gene.

Authors:  B D Theophilus; T Latham; G A Grabowski; F I Smith
Journal:  Nucleic Acids Res       Date:  1989-10-11       Impact factor: 16.971

5.  Prediction of severity of Gaucher's disease by identification of mutations at DNA level.

Authors:  A Zimran; J Sorge; E Gross; M Kubitz; C West; E Beutler
Journal:  Lancet       Date:  1989-08-12       Impact factor: 79.321

6.  1448C mutation linked to the Pv1.1- genotype in Italian patients with Gaucher disease.

Authors:  R Tuteja; B Bembi; E Agosti; F E Baralle
Journal:  Hum Mol Genet       Date:  1993-06       Impact factor: 6.150

7.  Gaucher disease type 1: cloning and characterization of a cDNA encoding acid beta-glucosidase from an Ashkenazi Jewish patient.

Authors:  P N Graves; G A Grabowski; R Eisner; P Palese; F I Smith
Journal:  DNA       Date:  1988-10

8.  A mutation in the human glucocerebrosidase gene in neuronopathic Gaucher's disease.

Authors:  S Tsuji; P V Choudary; B M Martin; B K Stubblefield; J A Mayor; J A Barranger; E I Ginns
Journal:  N Engl J Med       Date:  1987-03-05       Impact factor: 91.245

9.  Gaucher disease associated with a unique KpnI restriction site: identification of the amino-acid substitution.

Authors:  E Beutler; T Gelbart
Journal:  Ann Hum Genet       Date:  1990-05       Impact factor: 1.670

10.  Sequence of two alleles responsible for Gaucher disease.

Authors:  C M Hong; T Ohashi; X J Yu; S Weiler; J A Barranger
Journal:  DNA Cell Biol       Date:  1990-05       Impact factor: 3.311

View more
  6 in total

1.  Spectrum of mutations in the Batten disease gene, CLN3.

Authors:  P B Munroe; H M Mitchison; A M O'Rawe; J W Anderson; R M Boustany; T J Lerner; P E Taschner; N de Vos; M H Breuning; R M Gardiner; S E Mole
Journal:  Am J Hum Genet       Date:  1997-08       Impact factor: 11.025

Review 2.  Variable clinical presentation in lysosomal storage disorders.

Authors:  M Beck
Journal:  J Inherit Metab Dis       Date:  2001       Impact factor: 4.982

3.  Enzyme replacement therapy for Gaucher's disease: the early Canadian experience.

Authors:  J J MacKenzie; D Amato; J T Clarke
Journal:  CMAJ       Date:  1998-11-17       Impact factor: 8.262

4.  Exhaustive screening of the acid beta-glucosidase gene, by fluorescence-assisted mismatch analysis using universal primers: mutation profile and genotype/phenotype correlations in Gaucher disease.

Authors:  D P Germain; J P Puech; C Caillaud; A Kahn; L Poenaru
Journal:  Am J Hum Genet       Date:  1998-08       Impact factor: 11.025

5.  MiRNA Expression in Patients with Gaucher Disease Treated with Enzyme Replacement Therapy.

Authors:  Łukasz Pawliński; Anna Polus; Ewa Tobór; Maria Sordyl; Marianna Kopka; Bogdan Solnica; Beata Kieć-Wilk
Journal:  Life (Basel)       Date:  2020-12-22

6.  Skeletal radiographic manifestations of GM2 gangliosidosis variant 0 (Sandhoff disease) in two Japanese domestic cats.

Authors:  Yoshihiko Yu; Daisuke Hasegawa; Yuji Hamamoto; Shunta Mizoguchi; Toshiki Fujimori; Yoshiaki Kubo; Md Shafiqul Islam; Osamu Yamato
Journal:  JFMS Open Rep       Date:  2022-02-14
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.